Jubilant Life Sciences stock slumps 5% after Q4 net loss

The company reported a net loss of Rs100.65cr in Q4FY19 on account of a one-time loan settlement with International Finance Corporation (IFC).

from India Infoline News Service http://bit.ly/2Wg42cS